Features
- Full Receptor Binding Domain (RBD) presented to immune system
- Glycosylated Fc activates immune system response
- Clinical studies show robust, neutralizing antibody production
- Designed to induce and/or augment antibody titers in patients
- Production uses established, high-volume methods
- Effective at microgram doses